![Karole A. Sutherland](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Karole A. Sutherland
Keine laufenden Positionen mehr
Profil
Karole A.
Sutherland worked as a Director of Clinical Operations at QLT, Inc. and as a Vice President of Clinical Operations at Allon Therapeutics, Inc.
Ehemalige bekannte Positionen von Karole A. Sutherland
Unternehmen | Position | Ende |
---|---|---|
QLT, Inc.
![]() QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - |
ALLON THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ALLON THERAPEUTICS INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
QLT, Inc.
![]() QLT, Inc. Miscellaneous Commercial ServicesCommercial Services QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada. | Commercial Services |